Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.11851/11911
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTunç, N.-
dc.contributor.authorBakar, M.E.-
dc.contributor.authorÇalişkan, B.-
dc.contributor.authorÖlmez, T.T.-
dc.contributor.authorŞeker, U.Ö.Ş.-
dc.date.accessioned2024-12-10T19:00:45Z-
dc.date.available2024-12-10T19:00:45Z-
dc.date.issued2024-
dc.identifier.isbn978-311132949-9-
dc.identifier.isbn978-311132948-2-
dc.identifier.urihttps://doi.org/10.1515/9783111329499-005-
dc.identifier.urihttps://hdl.handle.net/20.500.11851/11911-
dc.description.abstractThis chapter explores the progress and possibilities of cutting-edge cellular engineering for therapeutic purposes. This statement underscores the fundamental change in medical treatments, moving away from conventional medicines toward living therapeutic systems. It emphasizes the significance of synthetic biology in developing self-replicating systems that have the ability to independently diagnose, treat, and cure diseases. The study focuses on several important topics, including the development of genetic circuits for medical purposes, the use of the human microbiome as a therapeutic platform and its impact on health and disease, the promise of microbiome engineering, and novel approaches for delivering drugs and treating diseases. The chapter also explores the use of biomaterials such as biofilms and biomineralization in treatments, as well as the importance of cross-disciplinary collaboration in the development of therapeutic approaches. The incorporation of these advanced technology offers potential solutions for unfulfilled medical requirements and revolutionizes treatment strategies for a range of illnesses. © 2025 Walter de Gruyter GmbH, Berlin/Boston.en_US
dc.language.isoenen_US
dc.publisherDe Gruyteren_US
dc.relation.ispartofSynthetic Biology for Therapeutics: Engineering Cells for Living Drugsen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleNew Generation Cellular Engineering for Living Therapeuticsen_US
dc.typeBook Parten_US
dc.departmentTOBB ETÜen_US
dc.identifier.startpage119en_US
dc.identifier.endpage169en_US
dc.identifier.scopus2-s2.0-85208280777en_US
dc.institutionauthor-
dc.identifier.doi10.1515/9783111329499-005-
dc.authorscopusid58775615500-
dc.authorscopusid57933194500-
dc.authorscopusid59397541900-
dc.authorscopusid55452404600-
dc.authorscopusid35280845500-
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
item.openairetypeBook Part-
item.languageiso639-1en-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Show simple item record



CORE Recommender

Page view(s)

4
checked on Dec 16, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.